United States
Germany
Japan
United Kingdom
China
CNY 3,990.00
2周
Products
CNY 3,990.00
2周
CNY 3,990.00
2周
MAP2K1 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI3H3 (formerly 3H3)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 Mutant (G128v), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | G128v |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K1 Mutant (P124L), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | P124L |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Recombinant protein of human mitogen-activated protein kinase kinase 1 (MAP2K1), 1 mg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human mitogen-activated protein kinase kinase 1 (MAP2K1), 100 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
MAP2K1 Mutant (D67N), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | D67N |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2D4 (formerly 2D4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2B2 (formerly 2B2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI7E2 (formerly 7E2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 Mutant (E203Q), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 1 (MAP2K1) as transfection-ready DNA
| Mutation | E203Q |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
活动过滤器
优化搜索结果
Species
Reactivities
Applications
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
QC Levels
Pathways
- Acute myeloid leukemia (261)
- B cell receptor signaling pathway (261)
- Bladder cancer (261)
- Chemokine signaling pathway (261)
- Chronic myeloid leukemia (261)
- Colorectal cancer (261)
- Dorso-ventral axis formation (261)
- Endometrial cancer (261)
- ErbB signaling pathway (261)
- Fc epsilon RI signaling pathway (261)
- Fc gamma R-mediated phagocytosis (261)
- Focal adhesion (261)
- Gap junction (261)
- Glioma (261)
- GnRH signaling pathway (261)
- Insulin signaling pathway (261)
- Long-term depression (261)
- Long-term potentiation (261)
- MAPK signaling pathway (261)
- Melanogenesis (261)
- Melanoma (261)
- Natural killer cell mediated cytotoxicity (261)
- Neurotrophin signaling pathway (261)
- Non-small cell lung cancer (261)
- Oocyte meiosis (261)
- Pancreatic cancer (261)
- Pathways in cancer (261)
- Prion diseases (261)
- Progesterone-mediated oocyte maturation (261)
- Prostate cancer (261)
- Regulation of actin cytoskeleton (261)
- Renal cell carcinoma (261)
- T cell receptor signaling pathway (261)
- Thyroid cancer (261)
- Toll-like receptor signaling pathway (261)
- VEGF signaling pathway (261)
- Vascular smooth muscle contraction (261)
